Extrawell Pharmaceutical Holdings Limited (HKG:0858)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0860
+0.0030 (3.61%)
Jul 18, 2025, 9:41 AM HKT
109.76%
Market Cap198.37M
Revenue (ttm)55.43M
Net Income (ttm)222.64M
Shares Out2.39B
EPS (ttm)0.07
PE Ratio1.12
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume960,000
Average Volume30,126,000
Open0.0850
Previous Close0.0830
Day's Range0.0850 - 0.0860
52-Week Range0.0300 - 0.1240
Beta0.13
RSI64.32
Earnings DateJun 27, 2025

About HKG:0858

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through Manufacturing, Trading, and Gene Development segments. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis... [Read more]

Sector Healthcare
Founded 1998
Employees 163
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0858
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.